Camp4 Therapeutics (CAMP) Non Operating Investment Income (2025 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Non Operating Investment Income came in at -$6.2 million in Q1 2026, up 77.92% quarter-over-quarter from -$28.0 million in Q4 2025.
Camp4 Therapeutics (CAMP) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Non Operating Investment Income across 2 years of filings, most recently posting -$6.2 million for Q1 2026.
- Non Operating Investment Income for Q1 2026 came in at -$6.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.0 million (changed N/A YoY), and the FY2025 annual result was -$29.8 million, changed N/A from the prior year.
- Non Operating Investment Income came in at -$6.2 million for Q1 2026 at Camp4 Therapeutics, up from -$28.0 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of -$1.8 million in Q3 2025 to a low of -$28.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | -6.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.19 Mn |
| Mar 31, 2026 | -6.19 Mn |
| Dec 31, 2025 | -28.03 Mn |
| Dec 31, 2025 | -28.03 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Sep 30, 2025 | -1.80 Mn |